Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1975 Sep;29(3):433–443.

Inhibition of T- and B-lymphocyte functions by normal immunosuppressive protein.

N Hanna, R Kalderon, D Nelken
PMCID: PMC1445971  PMID: 51828

Abstract

Normal immunosuppressive protein (NIP) isolated from human plasma was studied in two well defined systems. (1) Spontaneous rosettes of sheep red blood cells with human peripheral blood lymphocytes and PHA-induced lymphocyte cytotoxicity as indicators for T-cell function. (2) Rosette formation tests of human lymphocytes with antibody-coated erythrocytes or erythrocytes coated with antibody and complement as well as antibody-induced lymphocyte-mediated cytotoxicity represented non-T-cell activity. While NIP did not inhibit the formation of any of the above mentioned rosettes, it practically prevented both PHA-induced and antibody-mediated lymphocyte cytotoxicity. Relatively small amounts of NIP inhibited PHA-induced cytotoxicity while higher doses were required for the inhibition of antibody-mediated lymphocyte cytotoxicity. Possible mechanisms of its suppressive activity are discussed. NIP was found to be heat-stable and did not show any species specificity, as NIP preparations from human plasma were immunosuppressive in human, mouse and guinea-pig systems.

Full text

PDF
433

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Basten A., Miller J. F., Sprent J., Pye J. A receptor for antibody on B lymphocytes. I. Method of detection and functional significance. J Exp Med. 1972 Mar 1;135(3):610–626. doi: 10.1084/jem.135.3.610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Britton S., Perlmann H., Perlmann P. Thymus-dependent and thymus-independent effector functions of mouse lymphoid cells. Comparison of cytotoxicity and primary antibody formation in vitro. Cell Immunol. 1973 Sep;8(3):420–434. doi: 10.1016/0008-8749(73)90133-0. [DOI] [PubMed] [Google Scholar]
  3. Cooperband S. R., Badger A. M., Davis R. C., Schmid K., Mannick J. A. The effect of immunoregulatory globulin (IRA) upon lymphocytes in vitro. J Immunol. 1972 Jul;109(1):154–163. [PubMed] [Google Scholar]
  4. Cooperband S. R., Bondevik H., Schmid K., Mannick J. A. Transformation of human lymphocytes: inhibition by homologous alpha globulin. Science. 1968 Mar 15;159(3820):1243–1244. doi: 10.1126/science.159.3820.1243. [DOI] [PubMed] [Google Scholar]
  5. Cooperband S. R., Davis R. C., Schmid K., Mannick J. A. Competitive blockade of lymphocyte stimulation by a serum immuno-regulatory alpha globulin (IRA). Transplant Proc. 1969 Mar;1(1):516–523. [PubMed] [Google Scholar]
  6. Davis R. C., Cooperband S. R., Mannick J. A. The effect of immunoregulatory alpha globulin (IRA) on antigen-mediated macrophage immobilization in vitro. J Immunol. 1971 Mar;106(3):755–760. [PubMed] [Google Scholar]
  7. Dukor P., Bianco C., Nussenzweig V. Bone marrow origin of complement-receptor lymphocytes. Eur J Immunol. 1971 Dec;1(6):491–494. doi: 10.1002/eji.1830010617. [DOI] [PubMed] [Google Scholar]
  8. Forman J., Möller G. The effector cell in antibody-induced cell mediated immunity. Transplant Rev. 1973;17(0):108–149. doi: 10.1111/j.1600-065x.1973.tb00125.x. [DOI] [PubMed] [Google Scholar]
  9. Froland S. S., Natvig J. B. Identification of three different human lymphocyte populations by surface markers. Transplant Rev. 1973;16:114–162. doi: 10.1111/j.1600-065x.1973.tb00119.x. [DOI] [PubMed] [Google Scholar]
  10. Glaser M., Cohen I., Nelken D. In vitro inhibition of plaque and rosette formation by globulin. J Immunol. 1972 Jan;108(1):286–288. [PubMed] [Google Scholar]
  11. Glaser M., Nelken D. Inhibitory effect of alpha-globulin on the second set allograft reaction. Proc Soc Exp Biol Med. 1972 Jul;140(3):996–998. doi: 10.3181/00379727-140-36597. [DOI] [PubMed] [Google Scholar]
  12. Glasgow A. H., Menzoian J. O., Cooperband S. R., Nimberg R. B., Schmid K., Mannick J. A. Immunoregulatory d-globulin: failure to inhibit antibody response when administered after antigen exposure. J Immunol. 1973 Jul;111(1):272–274. [PubMed] [Google Scholar]
  13. Hersh E. M., Drewinko B. Specific inhibition of lymphocyte blastogenic responses to mitogens by a factor produced by cultured human malignant lymphoma cells. Cancer Res. 1974 Jan;34(1):215–220. [PubMed] [Google Scholar]
  14. Jondal M., Holm G., Wigzell H. Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med. 1972 Aug 1;136(2):207–215. doi: 10.1084/jem.136.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. KAMRIN B. B. Successful skin bomografts in mature non-littermate rats treated with fractions containing alpha-globulins. Proc Soc Exp Biol Med. 1959 Jan;100(1):58–61. doi: 10.3181/00379727-100-24522. [DOI] [PubMed] [Google Scholar]
  16. Karpas A. B., Segre D. A nonspecific immunosuppressive material derived from normal bovine serum. Proc Soc Exp Biol Med. 1973 Oct 1;144(1):141–147. doi: 10.3181/00379727-144-37543. [DOI] [PubMed] [Google Scholar]
  17. MOWBRAY J. F. Effect of large doses of an alpha2-glycoprotein fraction on the survival of rat skin homografts. Transplantation. 1963 Jan;1:15–20. doi: 10.1097/00007890-196301010-00003. [DOI] [PubMed] [Google Scholar]
  18. Mannick J. A., Schmid K. Prolongation of allograft survival by an alpha globulin isolated from normal blood. Transplantation. 1967 Jul;5(4 Suppl):1231–1238. doi: 10.1097/00007890-196707001-00063. [DOI] [PubMed] [Google Scholar]
  19. Menzoian J. O., Glasgow A. H., Nimberg R. D., Cooperband S. R., Schmid K., Saporoschetz I., Mannick J. A. Regulation of T lymphocyte function by immunoregulatory alphaglobulin (IRA). J Immunol. 1974 Jul;113(1):266–273. [PubMed] [Google Scholar]
  20. Nelken D., Glaser M. Synergistic effect of -globulin and other immunosuppressive agents on rat skin allograft survival. Transplantation. 1972 Aug;14(2):268–269. doi: 10.1097/00007890-197208000-00020. [DOI] [PubMed] [Google Scholar]
  21. Perlmann P., Holm G. Cytotoxic effects of lymphoid cells in vitro. Adv Immunol. 1969;11:117–193. doi: 10.1016/s0065-2776(08)60479-4. [DOI] [PubMed] [Google Scholar]
  22. Ross G. D., Rabellino E. M., Polley M. J., Grey H. M. Combined studies of complement receptor and surface immunoglobulin-bearing cells and sheep erythrocyte rosette-forming cells in normal and leukemic human lymphocytes. J Clin Invest. 1973 Feb;52(2):377–385. doi: 10.1172/JCI107194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wisloff F., Froland S. S. Antibody-dependent lymphocyte-mediated cytotoxicity in man: no requirement for lymphocytes with membrane-bound immunoglobulin. Scand J Immunol. 1973;2(2):151–157. doi: 10.1111/j.1365-3083.1973.tb02026.x. [DOI] [PubMed] [Google Scholar]
  24. Wybran J., Carr M. C., Fudenberg H. H. The human rosette-forming cell as a marker of a population of thymus-derived cells. J Clin Invest. 1972 Oct;51(10):2537–2543. doi: 10.1172/JCI107069. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES